Global BioAccess Fund is a venture capital firm. Based in New York, United States. The known portfolio counts 6 companies, including Odyssey Therapeutics, Alveus Therapeutics, Cartography Biosciences, ShiraTronics, Nuvig Therapeutics and Acesion Pharma.
Is Global BioAccess Fund a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechClinical-stage BiotechDrug DiscoveryHealthcare OperationsPharma
Who to pitch at Global BioAccess Fund
Global BioAccess Fund portfolio companies (6)
- Odyssey Therapeutics
- Alveus Therapeutics
- Cartography Biosciences
- ShiraTronics
- Nuvig Therapeutics
- Acesion Pharma
Co-investors
Funds that share portfolio companies with Global BioAccess Fund.
Similar funds
Showing 20 of 100
About Global BioAccess Fund
The firm's listing covers sector Healthcare, and focus areas Biotech, Clinical-stage Biotech, Drug Discovery and Healthcare Operations; known deals cluster at Growth, Series A and Series B.
The team counts 4 people in our database. Lisa Wisniewski (Managing Director), Sonia Gulati (Principal) and Michael D Krepps (Venture Partner) are shown as the contacts to pitch.
Global BioAccess Fund shares portfolio companies with 20 other investment firms, among them JEITO, Lotte Hb and Avego.
Frequently asked questions
What is Global BioAccess Fund?
Global BioAccess Fund is a venture capital firm based in New York, United States, with a known portfolio of 6 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Global BioAccess Fund invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Clinical-stage Biotech, Drug Discovery and Healthcare Operations. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Global BioAccess Fund invest at?
The known deals of Global BioAccess Fund include Growth, Series A and Series B rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at Global BioAccess Fund?
3 of the 4 people on file at Global BioAccess Fund are listed as contacts for the firm. All 4 have their own profile page.
How do I contact Global BioAccess Fund?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 4 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal